Tonix Pharmaceuticals Holding Corp (TNXP)

SBC to Revenue

16.66%

Quarterly · Period ending:

TNXP logo

TNXP SBC to Revenue

Latest reported16.66%
TNXP Quarterly SBC/Revenue (0.00% → 16.66%)
High-resolution chart · PNG

TNXP sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tonix Pharmaceuticals Holding Corp SBC to Revenue — Quarterly
Period endingSBC to Revenue
16.6568%
28.642%
33.525%
0%
71.2212%
36.3112%
34.6243%
36.7824%
52.2645%
68.1708%
53.9296%
52.1183%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-71,800%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.